[Type 2 insulin-dependent diabetes: patient characteristics and effects of insulin therapy].
Duysinx
B
B
Département de Médecine, Université de Liège, Service de Diabétologie, Nutrition et Maladies m etaboliques.
Scheen
A J
AJ
Paquot
N
N
Daubresse
C
C
Castillo
M
M
Lefèbvre
P J
PJ
D001786:Blood Glucose / Q000032:analysis; D002096:C-Peptide / Q000032:analysis; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D006946:Hyperinsulinism / Q000097:blood; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage / Q000378:metabolism; D000078790:Insulin Secretion; D008297:Male; D008875:Middle Aged; D009765:Obesity; D012189:Retrospective Studies
D001786:Blood Glucose; D002096:C-Peptide; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin
Le diabète de type 2 insulinorequérant: caracteristiques des patients et effets de l'insulinothérapie.